All Stories

  1. COPD Across the Life Course: Is CC16 the Key to Early Prevention?

    Article • American Review of Respiratory Disease, January 2026, Oxford University Press (OUP)

    Dr Lydia Finney

  2. Breathing barriers: bridging lung health, research, and awareness

    Article • The Lancet Respiratory Medicine, August 2025, Elsevier

    Dr Sanjay Ramakrishnan, Dr Lydia Finney

  3. Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational Study

    Article • American Review of Respiratory Disease, June 2025, Oxford University Press (OUP)

    Dr Lydia Finney

  4. Select Airway Specialized Proresolving Mediators Are Associated with Recovery from Nonviral Chronic Obstructive Pulmonary Disease Exacerbations

    Article • American Review of Respiratory Disease, May 2025, Oxford University Press (OUP)

    Dr Lydia Finney

  5. Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease

    Article • AJP Lung Cellular and Molecular Physiology, January 2025, American Physiological Society

    Dr Lydia Finney

  6. Respiratory Syncytial Virus–related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study

    Article • American Review of Respiratory Disease, October 2024, Oxford University Press (OUP)

    Dr Lydia Finney

  7. Accelerated Lung Function Decline and Mucus–Microbe Evolution in Chronic Obstructive Pulmonary Disease

    Article • American Review of Respiratory Disease, August 2024, American Thoracic Society

    Dr Micheál Mac Aogáin, Dr Lydia Finney

  8. Selected updates on chronic obstructive pulmonary disease

    Article • Current Opinion in Pulmonary Medicine, December 2023, Wolters Kluwer Health

    Dr Lydia Finney

  9. Reply to Martinez-Garcia et al. and to Wang et al.

    Article • American Review of Respiratory Disease, November 2023, Oxford University Press (OUP)

    Dr Lydia Finney

  10. Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study

    Article • ERJ Open Research, November 2023, European Respiratory Society (ERS)

    Dr Lydia Finney

  11. A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease

    Article • American Review of Respiratory Disease, September 2023, Oxford University Press (OUP)

    Dr Lydia Finney

  12. Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease

    Article • Journal of Clinical Investigation, April 2022, American Society for Clinical Investigation

    Dr Lydia Finney

  13. Chronic obstructive pulmonary disease in sub-Saharan Africa

    Article • The International Journal of Tuberculosis and Lung Disease, March 2022, International Union Against Tuberculosis and Lung Disease

    Dr Lydia Finney

  14. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon

    Article • Journal of Allergy and Clinical Immunology, February 2021, Elsevier

    Dr Lydia Finney

  15. Intra-alveolar neutrophil-derived microvesicles are associated with disease severity in COPD

    Article • AJP Lung Cellular and Molecular Physiology, January 2021, American Physiological Society

    Dr Lydia Finney

  16. Repurposing Existing Drugs for the Treatment of COVID-19

    Article • Annals of the American Thoracic Society, October 2020, Oxford University Press (OUP)

    Dr Lydia Finney

  17. Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial

    Article • American Review of Respiratory Disease, August 2020, Oxford University Press (OUP)

    Dr Lydia Finney

  18. Antiviral immunity is impaired in COPD patients with frequent exacerbations

    Article • AJP Lung Cellular and Molecular Physiology, December 2019, American Physiological Society

    Andrew Reid, Conjoint Professor Peter Wark, Dr Punnam Chander Veerati, Dr Lydia Finney

  19. Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease

    Article • Science Translational Medicine, August 2019, American Association for the Advancement of Science

    Dr Lydia Finney

  20. Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease

    Article • American Review of Respiratory Disease, June 2019, American Thoracic Society

    Dr Lydia Finney

  21. Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?

    Article • Breathe, June 2019, European Respiratory Society (ERS)

    Dr Lydia Finney

  22. Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2019, Dove Medical Press

    Dr Lydia Finney

  23. Validity of the diagnosis of pneumonia in hospitalised patients with COPD

    Article • ERJ Open Research, April 2019, European Respiratory Society (ERS)

    Dr Lydia Finney

  24. Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD

    Article • September 2018, European Respiratory Society (ERS)

    Dr Lydia Finney

  25. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease

    Article • Journal of Allergy and Clinical Immunology, September 2018, Elsevier

    Dr Lydia Finney

  26. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations

    Article • Nature Communications, June 2018, Springer Science + Business Media

    Andrew Reid, Conjoint Professor Peter Wark, Dr Punnam Chander Veerati, Dr Lydia Finney

  27. P56 Human rhinovirus impairs phagocytosis of haemophilus influenzae in alveolar macrophages in chronic obstructive pulmonary disease

    Article • November 2017, BMJ

    Dr Lydia Finney

  28. T3 Human rhinovirus impairs the innate immune response to bacteria in monocyte derived macrophages from patients with chronic obstructive pulmonary disease

    Article • Thorax, November 2016, BMJ

    Dr Lydia Finney

  29. LATE-BREAKING ABSTRACT: Microbiology and radiology of pneumonia in COPD

    Article • September 2015, European Respiratory Society (ERS)

    Dr Lydia Finney

  30. Markers to differentiate between Kaposi's sarcoma and tuberculous pleural effusions in HIV-positive patients

    Article • The International Journal of Tuberculosis and Lung Disease, February 2015, International Union Against Tuberculosis and Lung Disease

    Dr Lydia Finney

  31. Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease

    Article • The Lancet Respiratory Medicine, November 2014, Elsevier

    Dr Lydia Finney

  32. Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2014, Taylor & Francis

    Dr Lydia Finney

  33. Experimental rhinovirus infection in COPD: Implications for antiviral therapies

    Article • Antiviral Research, February 2014, Elsevier

    Dr Lydia Finney

  34. P109 Do specialist non-CF bronchiectasis clinics improve quality of care?

    Article • Thorax, November 2013, BMJ

    Dr Lydia Finney

  35. Importance of Onsite Cytopathology at Endobronchial Ultrasound

    Article • American Review of Respiratory Disease, November 2013, Oxford University Press (OUP)

    Dr Lydia Finney

  36. Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review [Review article]

    Article • The International Journal of Tuberculosis and Lung Disease, May 2013, International Union Against Tuberculosis and Lung Disease

    Dr Lydia Finney

  37. The National Stroke Strategy – Is it Achievable?

    Article • Annals of The Royal College of Surgeons of England, November 2009, Royal College of Surgeons of England

    Dr Lydia Finney